Skip to content
info@ibsgranada.es
FacebookTwitterLinkedInInstagramYouTube
ibs logo.GRANADA
  • ibs.GRANADA
  • The Institute
    • The Institute
    • Organizational structure
    • Management Units
    • Economic information
    • Centers
    • Responsible Research and Innovation (RRI)
    • Researcher Area
    • Annual Reports ibs.GRANADA
    • Webmail access
    • Transparency
    • Partners
  • Research
    • Own Plan ibs.GRANADA
    • Research Areas
    • Research groups
    • Clinical research
    • Collaboration network between groups of the ibs.GRANADA
    • Researcher Finder
    • Publications Search
  • Innovation
    • Innovation
    • Technology Offers
    • Clinical practice guidelines
  • International
    • International Projects Unit
    • International Projects
    • International Networks
  • Training
    • Training
    • Research Sessions
    • Conferences and Courses
    • Mentoring Program ibs.GRANADA
    • PhD Programs
    • Official University Master's Degrees
  • News
    • Calls for applications
    • News
    • Events
  • Job vacancies
    • Job vacancies
    • Human Resources Strategy for Researchers of the European Commission (HRS4R)
  • Digital Platforms

Category: ibs.GRANADA

ibs.GRANADA  ·  News
May 13 2025

Researchers from GENyO and IBS.GRANADA are developing a platform to improve early diagnosis of prostate cancer.

A scientific team with members from the Granada Biosanitary Research Institute (ibs.GRANADA) and the Pfizer-University of Granada-Andalusian Regional Government Center for Genomics and Oncological Research (GENyO) has developed a new electrochemical platform capable of detecting epithelial extracellular vesicles (EpEVs), key emerging biomarkers for more accurate prostate cancer diagnosis.
Read more
May 9 2025

An innovative app developed at the San Cecilio Clinical Hospital with the support of IBS. GRANADA improves hand hygiene in healthcare facilities.

Safe Hands 3.0, designed in collaboration with a Granada-based startup and supported by ibs.GRANADA, promotes the prevention of healthcare-associated infections. Coinciding with the week in which World Hand Hygiene Day is celebrated, professionals and researchers from the San Cecilio Clinical University Hospital are presenting the new digital application […]
Read more
May 8 2025

The IBS. GRANADA is participating in a study that demonstrates the usefulness of the drug Nirsevimab in preventing severe forms of respiratory syncytial virus in infants.

Analysis indicates that this monoclonal antibody protects against the most severe forms of the disease. An Andalusian study, in which hospitals from across the region participated, in collaboration with the Granada Biosanitary Research Institute (ibs.GRANADA), the University of Granada, and the General Directorate of Public Health of the Regional Ministry of Health […]
Read more
May 7 2025

Too young for colorectal cancer… or not anymore?

For decades, colorectal cancer has been considered a disease of aging. However, in recent years, a worrying trend has emerged: the continued increase in colorectal cancer among young people, especially those between the ages of 20 and 49. This phenomenon, now recognized as a public health problem, is causing concern in the scientific community […]
Read more
May 6 2025

Andalusian scientists design a biogel that accelerates the healing of skin wounds.

The new product acts as a natural scaffold in tissues that accurately replicates the structure and composition of human skin, including its three main layers: the epidermis, the dermis, and the hypodermis. A multidisciplinary team made up of researchers from the University of Granada, members of the Biosanitary Research Institute ibs.GRANADA, […]
Read more
Apr 30 2025

A new study by IBS.GRANADA links exposure to bisphenols in food with overweight in girls.

The study, published in the journal Environmental Health, revealed that girls with greater exposure to bisphenol A had a nearly three times greater risk of becoming overweight or obese. Research by the Granada Biosanitary Research Institute (ibs.GRANADA) has identified a possible association between exposure to bisphenols, chemical compounds present in […]
Read more
Apr 23 2025

Córdoba joins the IMPaCT Cohort, a national study to investigate key health factors in Spain.

More than 1.200 people have already been recruited in the Andalusian nodes led by Dr. María José Sánchez, scientific director of ibs.GRANADA, professor at EASP, and principal investigator of the IMPaCT cohort in Andalusia. The city of Córdoba joins the IMPaCT Cohort, an ambitious epidemiological research project promoted by […]
Read more
1 2 ... 83 84

Search

Subscribe to our Newsletter

Satisfaction survey



Collaboration network

ibs.Granada logo

  • info@ibsgranada.es
  • Avda. De Madrid, 15
    External Consultation Pavilion, 2nd Floor
    18012 Grenada.
  • facebook icon
  • twitter icon
  • instagram icon
  • linkedin icon
  • youtube icon
University of Granada
Investigate +
© 2025 ibs.GRENADA
  • Legal Notice
  • Cookies Policy
  • Privacy Policy
  • Contact
  • Site map

We use cookies to offer you the best experience on our website.

You can learn more about which cookies we use or deactivate them in the .

X
ibs logo.GRANADA
Powered by  GDPR Cookie Compliance
Privacy summary

This website uses cookies so that we can offer you the best possible user experience. The information of the cookies is stored in your browser and performs functions such as recognizing you when you return to our website or helping our team understand which sections of the website you find most interesting and useful.

Technical and necessary cookies

The strictly necessary cookies must always be activated so that we can save your cookie settings preferences.

If you deactivate this cookie we will not be able to save your preferences. This means that every time you visit this website you will have to activate or deactivate cookies again.

Analytics and optimization

This website uses Google Analytics to collect anonymous information such as the number of visitors to the site, or the most popular pages.

Leaving this cookie active allows us to improve our website.

Please activate the strictly necessary cookies first so that we can save your preferences!

Cookies policy

More information about our Cookies policy